-
公开(公告)号:US20250026826A1
公开(公告)日:2025-01-23
申请号:US18276916
申请日:2022-02-16
Inventor: Jianping Huang
IPC: C07K16/28 , A61K39/00 , A61K39/395 , A61P35/00
Abstract: The present disclosure provides a method of treating cancer, comprising administering an anti-LAIR1 antibody to a subject suffering from a cancer that is resistant to checkpoint inhibitor blockade therapy.
-
公开(公告)号:US12186381B2
公开(公告)日:2025-01-07
申请号:US17142792
申请日:2021-01-06
Inventor: Anthony F. Barbet , Francy L. Crosby
Abstract: The invention pertains to the use of VirB10 to immunize a host against an infection by a bacterium having T4SS. The invention provides a vaccine comprising VirB10, a fragment of VirB10, a polynucleotide encoding VirB10 or a polynucleotide encoding a fragment of VirB10 and a pharmaceutically acceptable carrier and/or adjuvant. The invention also provides a method of immunizing a host against an infection caused by a bacterium having T4SS, the method comprising administering to the host a vaccine of the invention. The vaccines and the methods of the invention can be used to immunize against infections caused by bacteria having T4SS in dogs, rabbits, cats, pigs, cattle, sheep, goats, deer, horses, rodents and humans.
-
公开(公告)号:US20250007413A1
公开(公告)日:2025-01-02
申请号:US18742232
申请日:2024-06-13
Inventor: Shuo Wang , Qinghui Huang
Abstract: Impedance balancing of isolated converters to reduce common mode (CM) electromagnetic interference (EMI) noise over a wide frequency range. An impedance balanced isolator converter circuit comprises a plurality of resistor, inductor, and capacitor (RLC) branches (i) that are representative of a transformer circuit component, (ii) that are coupled in series with a plurality of respective noise source voltages, and (iii) comprise RLC parameters that are based on respective ones of a plurality of impedances associated with the transformer circuit component; a load impedance branch (i) that is representative of one or more transformer primary side circuit components and (ii) that is coupled in parallel with the plurality of RLC branches and the plurality of respective noise source voltages; and an RLC balance branch coupled in parallel with a first resistor, a first inductor, and a first capacitor that are associated with a first of the plurality of RLC branches.
-
公开(公告)号:US20240422545A1
公开(公告)日:2024-12-19
申请号:US18334765
申请日:2023-06-14
Inventor: Patrick G. TRAYNOR , Kevin BUTLER , Christian PEETERS , Tyler TUCKER
IPC: H04W12/12
Abstract: Methods described herein relate to identifying an audio rogue base station intercept of a call using a modified distance bounding algorithm. Methods may include: establishing a shared resource for a session with a remote end device; selecting a nonce and provide the nonce to the remote end device; generating a sequence of bits; dividing the sequence of bits into a predetermined number of sub-sequences; performing a bit exchange with the remote end device using dual tone multi-frequency (DTMF) tones; determining, from the bit exchange, an average time of transmission; and identifying the presence or absence of an adversary intercepting the session.
-
公开(公告)号:US20240415983A1
公开(公告)日:2024-12-19
申请号:US18706176
申请日:2022-10-31
Inventor: Sanford L. Boye , Shannon E. Boye
Abstract: The present disclosure provides for recombinant AAV therapies for the treatment of vision loss associated with Friedreich's ataxia. These therapies are designed for administration to subjects, such as human subjects, including humans diagnosed with or suffering from Friedreich's ataxia. The disclosed vectors comprise transgenes that encode frataxin protein, such as a FXN trans gene encoding human frataxin protein.
-
公开(公告)号:US20240398764A1
公开(公告)日:2024-12-05
申请号:US18700643
申请日:2022-10-12
Inventor: Daohong Zhou , Guangrong Zheng , Yonghan He , Liya Pi
IPC: A61K31/427 , A61P1/16 , A61P35/00
Abstract: Disclosed herein are methods of treating diseases and disorders associated with senescent cell accumulation (e.g., an age-related disease and/or liver disease, e.g., obesity, liver steatosis, non-alcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis, or hepatocellular carcinoma (HCC)) and methods of ameliorating insulin resistance, pre-diabetes, or diabetes. Also disclosed herein are methods of degrading B-cell lymphoma-2 (Bcl-2) and/or B-cell lymphoma-extra large (Bcl-xl) proteins and methods of killing a senescent cell.
-
公开(公告)号:US12156919B2
公开(公告)日:2024-12-03
申请号:US17738987
申请日:2022-05-06
Applicant: University of Florida Research Foundation, Incorporated , Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Inventor: David C. Bloom , Alfred S. Lewin , Donna M. Neumann , Zachary L. Watson , Sonal Sanjeev Tuli , Gregory Scott Schultz
IPC: A61K48/00 , A61P31/22 , C12N5/0793 , C12N15/113 , C12N15/86 , C12N15/861
Abstract: Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.
-
公开(公告)号:US12152088B2
公开(公告)日:2024-11-26
申请号:US17124384
申请日:2020-12-16
Inventor: Gregory Allan Hudalla , Dillon T. Seroski
Abstract: Provided herein are charge complementary peptides that can be optionally coupled to a cargo polypeptide that are capable of self-assembling under stimulating conditions. The charge complementary peptides can be capable of forming supramolecular structures. Also provided herein are methods of using the charge complementary peptides provided herein.
-
9.
公开(公告)号:US20240293398A1
公开(公告)日:2024-09-05
申请号:US16486223
申请日:2018-02-16
Inventor: Matthew D. Disney , Sai Pradeep Velagapudi
IPC: A61K31/496 , A61P35/00 , C07D235/18 , C12N15/10
CPC classification number: A61K31/496 , A61P35/00 , C07D235/18 , C12N15/1065
Abstract: RNA drug targets are pervasive in cells but methods to design small molecules that target them are sparse. Herein, we report a general approach to score the affinity and selectivity of RNA motif-small molecule interactions identified via selection. Named High Throughput Structure-Activity Relationships Through Sequencing (HiT-StARTS), HiT-StARTS is statistical in nature and compares input nucleic acid sequences to selected library members that bind a ligand via high throughput sequencing. The approach allowed facile definition of the fitness landscape of hundreds of thousands of RNA motif-small molecule binding partners. These results were mined against folded RNAs in the human transcriptome and identified an avid interaction between a small molecule and the Dicer nuclease-processing site in the oncogenic microRNA (miR)-18a hairpin precursor, which is a member of the miR-17-92 cluster. Application of the small molecule, Targapremir-18a, to prostate cancer cells inhibited production of miR-18a from the cluster, de-repressed serine/threonine protein kinase 4 protein (STK4), and triggered apoptosis. Profiling the cellular targets of Targapremir-18a via Chemical Cross Linking and isolation by Pull Down (Chem-CLIP), a covalent small molecule-RNA cellular profiling approach, and other studies showed specific binding of the compound to the miR-18a precursor, revealing broadly applicable factors that govern small molecule drugging of non-coding RNAs.
-
公开(公告)号:US12071610B2
公开(公告)日:2024-08-27
申请号:US17140696
申请日:2021-01-04
Inventor: Zhonghui Hugh Fan , Xiao Jiang , Trevor B. Tilly , John Lednicky , Chang-Yu Wu
IPC: C12M1/34 , B01L3/00 , C12M1/36 , C12M3/00 , G01N33/569
CPC classification number: C12M41/46 , B01L3/527 , C12M23/44 , C12M41/48 , G01N33/56916 , G01N33/56983 , B01L2200/025 , B01L2200/026 , B01L2200/028 , B01L2400/0616
Abstract: An apparatus and method are provided for performing detection of microorganisms (e.g., viruses) with high sensitivity. The apparatus and method are well suited for point-of-care (POC) testing in resource-limited regions and are capable of being operated with very little manual intervention and without the need for lab equipment. A variety of viruses can be detected with high sensitivity, including, for example, coronaviruses, Zika virus and flu viruses.
-
-
-
-
-
-
-
-
-